Roche Holding | Stammkapital



Ordinary Share Capital Veränderung Datum
AbbVie USD 18M 0 2024-12
Alcon AG USD 20M 0 2025-03
Almirall EUR 214.79M 189.17M 2025-06
Amgen USD 538M 33.04B 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Bayer EUR 982.42M 1.53B 2025-06
Biogen USD 146.6M 146.5M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Fresenius EUR 563.24M 237K 2025-06
Fresenius Medical Care EUR 293.41M 0 2025-06
Galapagos EUR 65.9M 228.04M 2025-06
Genmab DKK 10M 56M 2025-03
Gilead Sciences USD 1.24B 3M 2025-06
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
GRIFOLS EUR 680.41M 560.8M 2025-06
Hikma Pharmaceutical USD 40M 0 2024-12
Lonza CHF 72M 0 2024-12
Merck EUR 434.78M 130.22M 2025-06
Merck USD 1.79B 0 2025-03
Novartis USD 793M 0 2024-12
Orion EUR 140.69M 48.49M 2025-06
Pfizer USD 5.68B 5.2B 2025-06
Philips EUR 950.57M 762.57M 2025-06
Recordati EUR 205.56M 179.42M 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
Sanofi 1.22B 36.5M 2025-06
UCB EUR 584M 0 2024-12


Roche Holding Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.